ActiGraft+

ActiGraft+

ActiGraft+ is an autologous, point-of-care wound management system created from your patient's whole blood. Once applied, the blood clot serves as a protective covering and optimizes the body's own healing potential.

RELIABLE OUTCOMES

Sustains a PAR rate of >/= 25% within 3 weeks of use and a 72% complete closure rate in 12 weeks.

COST-EFFECTIVE

Introducing ActiGraft+ into your facility can reduce woundcare spend up to 40%.

EASY-TO-MANAGE

Created using proprietary calcium gluconate powder that produces a thick, easy-to-apply whole blood clot.

SIMPLIFIED PROCESS

Needle-less blood transfer and 5-minute coagulation provides a clean, quick and easy preparation requiring no capital equipment.

PATIENT COMFORT

Fast healing with less wound interaction, increases patient satisfaction scores.

NATURAL HEALING

Provides the wound with an optimal, natural healing environment allowing the healing process to proceed unhindered.

ActiGraft Procedure

ActiGraft Uses

ActiGraft can be used for a wide variety of hard-to-treat chronic wounds, including but not limited to:

  • Diabetic/Neuropathic ulcers
  • Pressure Ulcers/Injury
  • Venous Stasis Ulcers
  • Surgical Debridement wounds
  • Traumatic wounds
  • Skin Tears

 

Contraindications:
ActiGraft is contraindicated in patients with the following types of wounds:

  • Wounds due to malignancy
  • Wounds with active clinically diagnosed infection

Technical Specs

  • Radius of ActiGraft clot – 3cm (Diameter 6sq cm)
  • Clot size: 28.3sq cm
  • 20ml of blood required
  • Storage conditions - Store in the original container at a room temperature of 5°C (41°F) – 30°C (86°F). Protect from freezing and avoid excessive heat.
This product may be protected by one or more patents. For further information please visit:
www.reddressmedical.com/patents
crossmenu